SPECIALTY
Biotechnology

STAGE
Clinical stage

WEBSITE
https://www.abilitypharma.com/

POSITION
Co-Lead

BOARD
Board Director & Board Observer

Ability Pharmaceuticals (Ability Pharma) is a clinical-stage biotherapeutics company developing a novel approach to treating cancer through autophagy. Ability Pharma’s lead asset, ABTL-0812, is in a Ph2b trial for first-line metastatic pancreatic cancer. CTI Life Sciences Fund (CTI) co-led the latest funding round of the Company and has both board director and board observer positions.